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Abstract
Medical Immunology will be publishing invited Reviews and Commentaries from investigators who
are at the forefront of their fields, to up-date our readers as to the current state of their art. These
Reviews and Commentaries will be accompanied by Editorials that place the current work into the
perspective of the first contribution in an area, which resulted in a "Classic" paper. Where possible,
links will be provided to the original publication, so that the modern student of immunology can
read the original and draw their own conclusions as to the value of the "Classic" contribution, and
its relationship to our contemporary views as to how the immune system functions. To begin this
process at the very dawn of immunology, we highlight Sir Edward Jenner's first descriptions of the
use of cowpox to immunize individuals against the dread disease smallpox.
With this editorial, Medical Immunology embarks on a
new endeavor. One of the advantages of the electronic/
digital age is that so much of the scientific literature is now
available to everyone, not only to those with access to the
specialized scientific or medical libraries. However, unless
one knows which author/investigator/topic to seek out, it
is still difficult for the student or layperson to know where
to begin and which key words to use in the search engines.
Accordingly, Medical Immunology now is devoted to an
historical development of the field of immunology, much
of which was organized chronologically in my first edito-
rial[1], which attempted to justify why we needed a new
on-line journal devoted to Medical Immunology. So
much of the more recent scientific literature is difficult for
one who is uninitiated in the science to be able to just pick
up and read outright, because each contribution usually
describes only a segment of a larger work by the authors
and many others, and each individual contribution is but
a very small part of a much larger area of investigation. As
well, if one is not schooled in the vocabulary, it is difficult,
if not impossible to begin to understand experiments per-
formed and the significance of the findings reported.
I have developed a method of inquiry of the scientific lit-
erature when embarking on a new subject that works for
me, and allows me to organize the experimental findings
and to rank them in importance one with another. Thus,
I take a chronological approach, beginning with the very
first report in a particular field, and then tracing the papers
forward in time. This approach has the advantage of start-
ing way in the past, at a time when often the concepts and
methods of investigation were quite simple and therefore
more easily understood, so that as one studies more recent
reports it is much easier to appreciate the significance of a
new approach or fresh insight into an old problem.
Therefore, with this as background, we begin our course in
immunology with Sir Edward Jenner's "An Inquiry into the
Causes and Effects of the Variolae Vaccinae, a Disease Dis-
covered in some of the Western Counties of England, partic-
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ularly Goucestershire, and known by the name of The Cow
Pox", which was published in 1798 [2].
Reading through this detailed account of Jenner's experi-
ments, which he conducted over several years, one is
struck by the meticulous care this country doctor made in
documenting his efforts, as well as his powers of observa-
tion, which allowed him to identify the unique character-
istics of the cowpox lesions, so that he could transfer only
the liquid from cowpox pustules from one individual to
another. Of course, unbeknownst to Jenner at the time
were the myriad of microorganisms that could mimic
such pustules, such as the pyogenic bacteria such as sta-
phylococci and streptococci. If he had not been so careful
to detail and identify the characteristics of the cowpox
lesions, he could have missed the observations that
started the science of immunology, and that led to his
worldwide fame and his Knighthood, as well as his life-
time pension from the Crown.
It is perhaps ironic that we find ourselves 207 years later
still concerned with smallpox, and concerned because of
the idea that this devastating organism could again be
used as a weapon of biological warfare. The stories of the
English soldiers, who gave smallpox-infected blankets to
the North American Indians during the French and Indian
Wars, are familiar to us. Now we are afraid that new for-
eign terrorists may do the same to us!
Even though Jenner's experiments showed us the way to
effective vaccination, and even though smallpox was
declared eradicated from the world in 1980, we still have
not understood how to make an effective and safe vaccine.
All of the vaccines that we have, including those devel-
oped empirically during the 1950's and 1960's, were
developed before our present understanding of how the
immune system functions, which has occurred only since
1970.
Unfortunately, because of the threat of bioterrorism, we
are now hard-pressed to invent, as rapidly as possible,
new vaccines to protect our population against smallpox,
as well as many of the very pathogenic microorganisms
for which we do not have safe and effective vaccines.
Accordingly, the questions as to how to construct new vac-
cines for smallpox, as well as many other infectious dis-
eases are paramount. In this regard, how to test for the
efficacy of vaccines is central to both the problem and the
solutions. Of course, Jenner monitored a successful "take"
of the cowpox inoculation as the development of a local-
ized lesion that resembled the cowpox lesions on the
hands of the milkmaids, and that resembled the skin
lesions that became generalized after a smallpox infec-
tion. Accordingly, because the cowpox virus actually rep-
licates in humans, it generated a localized self-limiting
infection that could not only be detected with the naked
eye, but by so doing, a very strong immunological stimu-
lus resulted, which left the host with long-lasting immu-
nological memory.
Now that we know much more than did Jenner more than
200 years ago about how the immune system functions,
one might imagine that it should be relatively easy to con-
struct a safe and effective smallpox vaccine. Therefore, to
begin our discussions in this regard, I have asked Mark
Slifka, from the Vaccine and Gene Therapy Institute at the
Oregon Health & Sciences University, to write a Commen-
tary on the current state of the art of immunity to small-
pox that can be detected by our most modern methods of
monitoring the immune response, and to identify where
we are, and where we need to go. Mark is especially suited
to educate us, in that his group has published one of the
most extensive analyses of the immunologic memory of
individuals vaccinated against smallpox, using modern
up-to-date methods [3].
This effort in Classics in Immunology should be construed
as an open invitation for investigators to send us contribu-
tions that deal with new approaches to smallpox vaccines,
as well as the use of smallpox vaccines as vectors for other
microbes. As well, it is an invitation to all readers to write
to the editors with questions or comments.
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